We are at the end of yet another year of the great reset. It’s the end of December — we can see Christmas trees everywhere, and the holiday cheer in the air — yet something feels off. Something’s off. We are busying around, we are going about our holiday tasks — but it feels a… Read More: Bidding Farewell to Another Year of “COVID”: Vigilance and Hope »
In 2018, researchers at the U.S. National Institutes of Health’s (NIH) Rocky Mountain Laboratories in Montana — a biolevel 4 facility — experimented with a SARS-like coronavirus to see if it would infect bats.1 The revelation came from a resurfaced study published by the group, which was flagged by activist group DRASTIC. The White Coat… Read More: US Lab Is Linked to COVID Virus, Before Outbreak »
September 11, 2023, the U.S. Food and Drug Administration announced1 it had approved reformulated monovalent COVID shots by Pfizer and Moderna for use in individuals 12 years of age and older. They also issued emergency use authorization (EUA) for use of the reformulated jabs in children aged 6 months to 11 years.2 The updated mRNA… Read More: New Non-mRNA ‘Emergency’ Vaccine Authorized for COVID »
Since the advent of the vaccination program, many Americans have lined up to get shots for themselves and their children that promise to eliminate the potential of disease. The FDA and pharmaceutical companies may be banking on Americans taking the new monovalent COVID booster, which the FDA announced on June 16, 2023,1 alongside their fall… Read More: New XBB COVID Combination Vax to Include Flu and RSV »